Related Experiment Videos
Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram
P J Perry1, K A Bever, S Arndt
1Department of Psychiatry, College of Medicine, University of Iowa, Iowa City 52242, USA.
Biological Psychiatry
|November 3, 1998
Summary
This study developed a clozapine dosing nomogram to predict optimal plasma concentrations. The nomogram helps clinicians personalize clozapine dosage for improved patient response and reduced trial time.
Area of Science:
- Pharmacology
- Psychiatry
- Clinical Pharmacy
Background:
- Clozapine dosing is influenced by factors like gender, smoking, and age.
- Therapeutic plasma concentrations (350-504 ng/mL) correlate with 55-80% response rates in refractory schizophrenia.
- Optimizing clozapine dosage can shorten treatment lag time.
Purpose of the Study:
- To develop a clozapine dosing nomogram for predicting steady-state plasma concentrations.
- To provide clinicians with a tool for more precise clozapine dose adjustments.
Main Methods:
- Retrospective chart review and patient interviews of 71 patients.
- Collection of clozapine steady-state plasma concentrations and demographic data.
- Multiple linear regression analysis to identify predictive variables for plasma concentration.
Main Results:
- A predictive model for clozapine concentrations included dose, smoking status, gender, and a dose-gender interaction.
- The model explained 47% of the variance in clozapine concentrations (r² = .47).
- Specific equations were derived for male and female subjects to predict clozapine levels.
Conclusions:
- A clozapine dosing nomogram was successfully constructed.
- The nomogram serves as a clinical aid to guide clozapine dosing decisions.